A Multicenter, Randomised, Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously
Phase of Trial: Phase III
Latest Information Update: 06 May 2019
Price : $35 *
At a glance
- Drugs Vinflunine (Primary) ; Capecitabine
- Indications Advanced breast cancer; Carcinoma
- Focus Registrational; Therapeutic Use
- Sponsors Pierre Fabre
- 31 Aug 2018 Biomarkers information updated
- 27 Sep 2017 Status changed from active, no longer recruiting to completed.
- 02 Feb 2017 Planned End Date changed from 1 Feb 2017 to 1 Apr 2017.